We have located links that may give you full text access.
Long-term fate of C3-7 arthrodesis: 4-level ACDF versus Cervical Laminectomy and Fusion.
Journal of Neurosurgical Sciences 2018 October 3
INTRODUCTION: Cervical spondylotic myelopathy (CSM) most commonly occurs at the C3-7 levels and is successfully treated by multilevel anterior cervical discectomy and fusion (ACDF) or cervical laminectomy and fusion (CLF), but no procedure has clearly demonstrated superiority. Most prior investigations comparing approaches are limited by marked heterogeneity in the composition of the study groups. This investigation compares ACDF versus CLF surgery specifically at C3-7 in terms of long-term neurological outcome and the fate of the adjacent levels.
METHODS: Over a twelve-year period, surgeries to treat CSM at C3-7 by ACDF or CLF were retrospectively reviewed. Demographic/clinical data were recorded, pre/post- operative modified Japanese orthopedic association scores (mJOA) were calculated, and any complications were noted.
RESULTS: Of 781 cervical surgery patients, 15 underwent C3-7 ACDF and 49 CLF. There were no differences in patient characteristics or pre/postoperative mJOA scores. Mean follow-up was 52 and 44 months for the anterior and posterior groups respectively. A complication occurred in 3/15 (21%) of the anterior and 14/49 (28%) of the posterior group. No infections occurred in ACDF patients, but there were three in CLF patients. Pseudoarthrosis occurred in two ACDF patients, neither associated with symptoms. Four in the CLF group had asymptomatic pseudoarthroses; two others needed reoperation for kyphosis at the inferior level.
CONCLUSIONS: Long-term neurological improvement occurs following C3-7 ACDF and CLF to a similar degree. While not statistically significant, fewer complications, were seen following ACDF. The absence of symptomatic adjacent segment degeneration (ASD) following ACDF in this series raises a question for further study whether the statistical likelihood of ASD changes once the C3-7 levels are already fused.
METHODS: Over a twelve-year period, surgeries to treat CSM at C3-7 by ACDF or CLF were retrospectively reviewed. Demographic/clinical data were recorded, pre/post- operative modified Japanese orthopedic association scores (mJOA) were calculated, and any complications were noted.
RESULTS: Of 781 cervical surgery patients, 15 underwent C3-7 ACDF and 49 CLF. There were no differences in patient characteristics or pre/postoperative mJOA scores. Mean follow-up was 52 and 44 months for the anterior and posterior groups respectively. A complication occurred in 3/15 (21%) of the anterior and 14/49 (28%) of the posterior group. No infections occurred in ACDF patients, but there were three in CLF patients. Pseudoarthrosis occurred in two ACDF patients, neither associated with symptoms. Four in the CLF group had asymptomatic pseudoarthroses; two others needed reoperation for kyphosis at the inferior level.
CONCLUSIONS: Long-term neurological improvement occurs following C3-7 ACDF and CLF to a similar degree. While not statistically significant, fewer complications, were seen following ACDF. The absence of symptomatic adjacent segment degeneration (ASD) following ACDF in this series raises a question for further study whether the statistical likelihood of ASD changes once the C3-7 levels are already fused.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
Perioperative echocardiographic strain analysis: what anesthesiologists should know.Canadian Journal of Anaesthesia 2024 April 11
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app